Empowering Patients
Taking Cancer on Through Flavour
Simple, nutritious recipes for people with cancer
Search
854 Result(s)
Science Stories
Taking KRAS Cancer On
Hear from Darryl McConnell, Research Site Head, Vienna, as he describes how we aim to drug all forms of KRAS
Cancer
Taking Cancer On: The Podcast
From early stage discovery to clinical trials and approval, we’re Taking Cancer On. Click here to access the podcast homepage, where you will find all the available episodes.
Empowering Patients
Taking Cancer on Together
Find out how our colleagues are empowering patients to Take Cancer On through their work.
Article
Taking Cancer on at Diagnosis
Video capturing patient, partner and HCP advice for people starting their own cancer journeys.
More Green
Taking action to reduce plastic waste
By using creativity and persistence, the packaging department team at Yamagata, Japan, managed to reduce their waste plastic material by 11 per cent, making them an inspiration for all sites globally.
Science Focus
Oncology and Cancer Immunology
Lung Cancer
Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, accounting for 80-85% of all lung cancer cases. Find out more about testing and treatment here.
Science Stories
Protein Degraders: Changing the Game in Cancer Drug Discovery
Boehringer Ingelheim scientists and their partners are exploring how protein degraders could bring so-called undruggable cancer targets within reach
Cancer
Why cancer care is personal for us
Find out more about Boehringer Ingelheim’s generational commitment to transforming cancer care.
January 09, 2023
New cancer therapeutics collaboration with 3T Bio
Science Stories
Targeting HER2 in cancer: The story of zongertinib
Our cancer researchers share insights into the discovery of zongertinib, our investigational HER2 tyrosine kinase inhibitor.
January 04, 2024
Boehringer Ingelheim and 3T Biosciences enter into a second partnership to develop next-generation cancer immunotherapies
September 21, 2021
Acquisition to advance cancer immunology research
Science Stories
SIRPα: A New Chapter in Cancer Immunology Research
Boehringer Ingelheim scientists are exploring a research path scientifically less travelled by investigating a new target in the innate immune system
Across Cancer Types
Cancer’s Big 4, our focus on KRAS
Drugging the undruggable
Science Stories
What does it mean to drug cancer’s “big four”?
Learn how Darryl McConnell & his team are tackling one of the biggest scientific conundrums.
June 02, 2022
A*STAR antibodies bolster ADC and T-Cell engager development
Pets
A brighter future for pets with cancer
Our R&D team's efforts toward finding new cancer treatments for pets
Lung Cancer
Keith and Heather’s Story
Having lost his left lung to cancer, Keith faced a challenging road to recovery but didn’t allow it to limit his lifestyle or ambitions.
Gastrointestinal Cancers
Brightline-2 trial launch in biliary tract and pancreatic cancers
Find out more about the Brightline-2 trial and our commitment to people living with biliary tract and pancreatic cancers.
Science Stories
“My ultimate goal is to cure cancer”
Norbert Kraut, our Global Head of Cancer Research, shares how we are advancing science to bring new treatments for people with cancer.
Article
Dietary Advice for Specific Cancers
Hear Dr. Clare Shaw’s recommendations for seeking specific cancer nutrition advice
Article
Weight Loss from Cancer Treatment
Dr. Clare Shaw offers her advice for patients who have lost weight during cancer treatment and would like to put it back on. Click here to learn more.
Article
High Protein Diets for Cancer Patients
A high protein diet may be advisable when undertaking cancer treatment. Click here to learn more from Dr. Clare Shaw.